United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2005_register
executive
2010-09-23
article
Notice of Intent To Grant Partially Exclusive License
Notices
D09002ee1bde2ad5f
D09002ee1bde2add2
United States
National Aeronautics and Space Administration
originator
org
United States Government Agency or Subagency
This notice is issued in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant a partially exclusive license in the United States to practice the inventions described and claimed in U.S. Patent Nos. 5,153,131, entitled ``High Aspect Reactor Vessel and Method of Use''; 5,153,132, entitled ``Three-Dimensional Co-culture Process''; 5,153,133, entitled ``Method for Culturing Mammalian Cells in a Horizontally Rotated Bioreactor''; 5,155,034, entitled ``Three Dimensional Cell to Tissue Assembly Process''; 5,155,035, entitled `` Method for Culturing Mammalian Cells in a Perfused Bioreactor''; 5,308,764, entitled ``Multi-Cellular Three-Dimensional Living Mammalian Tissue''; 5,496,722, entitled ``Method for Producing Non-neoplastic, Three- dimensional, Mammalian Tissue and Cell Aggregates under Microgravity Culture Conditions and the Products Produced Therefrom''; 5,627,021, entitled ``Three- Dimensional Co-Culture Process''; 5,637,477, entitled ``Recombinant Protein Production and Insect Cell Culture and Process''; 5,846,807, entitled ``Media Compositions for Three-dimensional Mammalian Tissue Grown under Microgravity Culture Conditions''; 5,851,816, entitled ``Cultured High-Fidelity Three-Dimensional Human Urogenital Tract Carcinomas and Process''; 5,858,783, entitled ``Production of Normal Mammalian Organ Culture Using a Medium Containing MEM-alpha, Leibovitz L-15, Glucose Galactose Fructose''; 5,962,324, entitled ``Three Dimensional Optic Tissue Culture and Process''; 6,177,674, entitled ``Pathogen Propagation in Cultured Three-Dimensional Tissue Mass''; 6,485,963, entitled ``Growth Stimulation of Biological Cells and Tissue by Electromagnetic Fields and Uses Thereof'', 6,673,597, entitled ``Growth Stimulation of Biological Cells and Tissue by Electromagnetic Fields and Uses Thereof''; 6,730,498, entitled ``Production of Functional Proteins: Balance of Shear Stress and Gravity''; 6,946,246, entitled ``Production of Functional Proteins: Balance of Shear Stress and Gravity'', and U.S. Patent Application Serial Number 10/734,759, entitled ``Production of Functional Proteins: Balance of Shear Stress and Gravity'', U.S. Patent Application Serial Number 10/947,786, entitled ``Production of Functional Proteins: Balance of Shear Stress and Gravity'', to Renautus Bio Therapeutics, LLC, having its principal place of business in Baton Rouge, LA. The patent rights in the inventions have been assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. The prospective partially exclusive license will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.
70 FR 66861
https://www.govinfo.gov/app/details/FR-2005-11-03/05-21897
05-21897
fr03no05-77
7510-13-P
Notice (05-149)
https://www.govinfo.gov/app/details/FR-2005-11-03/05-21897
https://www.govinfo.gov/content/pkg/FR-2005-11-03/html/05-21897.htm
https://www.govinfo.gov/content/pkg/FR-2005-11-03/pdf/05-21897.pdf
2 p.
66861
66862
70 FR 66861
Notice of Intent To Grant Partially Exclusive License; Federal Register Vol. 70, Issue
NOTICE
05-21897
NATIONAL AERONAUTICS AND SPACE ADMINISTRATION
Notice (05-149)
7510-13-P
05-21897
Notice of intent to grant partially exclusive license.
This notice is issued in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant a partially exclusive license in the United States to practice the inventions described and claimed in U.S. Patent Nos. 5,153,131, entitled ``High Aspect Reactor Vessel and Method of Use''; 5,153,132, entitled ``Three-Dimensional Co-culture Process''; 5,153,133, entitled ``Method for Culturing Mammalian Cells in a Horizontally Rotated Bioreactor''; 5,155,034, entitled ``Three Dimensional Cell to Tissue Assembly Process''; 5,155,035, entitled `` Method for Culturing Mammalian Cells in a Perfused Bioreactor''; 5,308,764, entitled ``Multi-Cellular Three-Dimensional Living Mammalian Tissue''; 5,496,722, entitled ``Method for Producing Non-neoplastic, Three- dimensional, Mammalian Tissue and Cell Aggregates under Microgravity Culture Conditions and the Products Produced Therefrom''; 5,627,021, entitled ``Three- Dimensional Co-Culture Process''; 5,637,477, entitled ``Recombinant Protein Production and Insect Cell Culture and Process''; 5,846,807, entitled ``Media Compositions for Three-dimensional Mammalian Tissue Grown under Microgravity Culture Conditions''; 5,851,816, entitled ``Cultured High-Fidelity Three-Dimensional Human Urogenital Tract Carcinomas and Process''; 5,858,783, entitled ``Production of Normal Mammalian Organ Culture Using a Medium Containing MEM-alpha, Leibovitz L-15, Glucose Galactose Fructose''; 5,962,324, entitled ``Three Dimensional Optic Tissue Culture and Process''; 6,177,674, entitled ``Pathogen Propagation in Cultured Three-Dimensional Tissue Mass''; 6,485,963, entitled ``Growth Stimulation of Biological Cells and Tissue by Electromagnetic Fields and Uses Thereof'', 6,673,597, entitled ``Growth Stimulation of Biological Cells and Tissue by Electromagnetic Fields and Uses Thereof''; 6,730,498, entitled ``Production of Functional Proteins: Balance of Shear Stress and Gravity''; 6,946,246, entitled ``Production of Functional Proteins: Balance of Shear Stress and Gravity'', and U.S. Patent Application Serial Number 10/734,759, entitled ``Production of Functional Proteins: Balance of Shear Stress and Gravity'', U.S. Patent Application Serial Number 10/947,786, entitled ``Production of Functional Proteins: Balance of Shear Stress and Gravity'', to Renautus Bio Therapeutics, LLC, having its principal place of business in Baton Rouge, LA. The patent rights in the inventions have been assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. The prospective partially exclusive license will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.
The prospective exclusive license may be granted unless, within fifteen (15) days from the date of this published notice, NASA receives written objections including evidence and argument that establish that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. Competing applications completed and received by NASA within fifteen (15) days of the date of this published notice will be treated as objections to the grant of the contemplated partially exclusive license.
Kurt G. Hammerle, Patent Attorney, NASA Johnson Space Center, Mail Stop AL, Houston, TX 77058-8452, Telephone: (281) 483-1001, Facsimile: (281) 483-6936. Information about other NASA inventions available for licensing can be found online at http://technology.nasa.gov/.
Patent licenses; non-exclusive, exclusive, or partially exclusive:
Renautus Bio Therapeutics, LLC,
http://technology.nasa.gov/
Federal Register
Vol. 70, no. 212
Office of the Federal Register, National Archives and Records Administration
2005-11-03
continuing
daily
deposited
born digital
347 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2005-11-03
P0b002ee1809878c6
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr03no05
https://www.govinfo.gov/app/details/FR-2005-11-03
https://www.govinfo.gov/content/pkg/FR-2005-11-03/pdf/FR-2005-11-03.pdf
https://www.govinfo.gov/content/pkg/FR-2005-11-03/xml/FR-2005-11-03.xml
fdlp
66747
67083
DGPO
2010-09-23
2023-05-03
FR-2005-11-03
machine generated
eng
FR
FR-2005-11-03
70
212